Covington Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Covington Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$109K	Hold	825	–	–	﹤0.01%	449
2022 Q2	$112K	Hold	825	–	–	﹤0.01%	443
2022 Q1	$123K	Hold	825	–	–	﹤0.01%	444
2021 Q4	$134K	Hold	825	–	–	﹤0.01%	405
2021 Q3	$137K	Hold	825	–	–	0.01%	401
2021 Q2	$142K	Buy	+825	New	+$136K	0.01%	397

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SOS

Silver Oak Securities Jackson, Tennessee $1.37B AUM 20.67% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Covington Capital Management's FBT Position: Q3 2022 in Review

Covington Capital Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q3 2022 at 825 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

Covington Capital Management first reported a position in FBT in Q2 2021 and has held it in 6 quarters since. The position peaked at $142K in Q2 2021. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.

Covington Capital Management held 825 shares of First Trust NYSE Arca Biotechnology Index Fund worth $109K as of Q3 2022.
Covington Capital Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q3 2022.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #449 holding.
Covington Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2021 and has held it in 6 quarters since.
Covington Capital Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $142K in Q2 2021.
218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.